Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Bioorganic & Medicinal Chemistry Letters|December 11, 2017
Recent encounters with atropisomerism in drug discoveryPeter W GlunzBioorganic & Medicinal Chemistry Letters|March 6, 2003
Design and synthesis of bicyclic pyrimidinone-based HCV NS3 protease inhibitorsPeter W Glunz, Brent D Douty, Carl P DeciccoBioorganic & Medicinal Chemistry Letters|April 29, 2023
Phthalazinone-based lactams and cyclic ureas as ROCK2 selective inhibitorsZilun Hu, Doree Sitkoff, Peter W Glunz, et al.Proceedings of the National Academy of Sciences of the United States of America|October 3, 2002
On the power of chemical synthesis: immunological evaluation of models for multiantigenic carbohydrate-based cancer vaccinesGovindaswami Ragupathi, Don M Coltart, Lawrence J Williams, et al.Bioorganic & Medicinal Chemistry Letters|April 18, 2015
Design and synthesis of potent, selective phenylimidazole-based FVIIa inhibitorsPeter W Glunz, Xuhong Cheng, Daniel L Cheney, et al.Journal of Medicinal Chemistry|March 26, 2016
Atropisomer Control in Macrocyclic Factor VIIa InhibitorsPeter W Glunz, Luciano Mueller, Daniel L Cheney, et al.Journal of the American Chemical Society|August 15, 2002
Principles of mucin architecture: structural studies on synthetic glycopeptides bearing clustered mono-, di-, tri-, and hexasaccharide glycodomainsDon M Coltart, Ajay K Royyuru, Lawrence J Williams, et al.Bioorganic & Medicinal Chemistry Letters|September 11, 2016
Synthesis and P1' SAR exploration of potent macrocyclic tissue factor-factor VIIa inhibitorsVladimir Uladzimir Ladziata, Peter W Glunz, Yan Zou, et al.Bioorganic & Medicinal Chemistry Letters|February 19, 2013
Design and synthesis of bicyclic pyrazinone and pyrimidinone amides as potent TF-FVIIa inhibitorsXiaojun Zhang, Peter W Glunz, Wen Jiang, et al.Bioorganic & Medicinal Chemistry Letters|July 13, 2013
Nonbenzamidine acylsulfonamide tissue factor-factor VIIa inhibitorsPeter W Glunz, Xiaojun Zhang, Yan Zou, et al.Pageof 2